Eltrombopag: a stem cell cookie?
- 20 March 2014
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 123 (12), 1774-1775
- https://doi.org/10.1182/blood-2014-02-553404
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drugBlood, 2014
- Current concepts in the pathophysiology and treatment of aplastic anemiaHematology-American Society Hematology Education Program, 2013
- Somatic Mutations Implicated In Myeloid Malignancies Are Frequent In Idiopathic Aplastic Anaemia and Its Relevance To Disease Classification and Treatment- a Comprehensive Analysis Of 150 PatientsBlood, 2013
- Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathyBlood, 2013
- Eltrombopag and Improved Hematopoiesis in Refractory Aplastic AnemiaNew England Journal of Medicine, 2012
- Functional characterization of CD4(+) T cells in aplastic anemiaBlood, 2012
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agentsBlood, 2010
- Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptorProceedings of the National Academy of Sciences of the United States of America, 2006